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Abstract
Background: Previous work has highlighted the importance of the neutrophil-to-lymphocyte ratio 
(NLR) and the difference in the ward-to-catheterization laboratory systolic blood pressure (DSBP) in 
prognostic stratification after acute coronary syndrome. However, there is paucity of data regarding the 
added value of combining these two variables to predict 5-year major clinical outcomes after percutane-
ous coronary intervention. 
Methods: A total of 1188 patients were classified into four groups according to the NLR and DSBP 
(high vs. low) using cutoffs derived from an analysis of receiver operating characteristic curves. A NLR 
> 3.0 and a DSBP > 25 mmHg were considered high values. The primary endpoint was the composite 
of all-cause death, cardiac death, and non-fatal myocardial infarction. The secondary endpoint was the 
composite of target lesion revascularization, target vessel revascularization, and incidence of cerebro-
vascular accidents. 
Results: The incidence of the primary endpoint was significantly higher in the high NLR and DSBP 
group than in the other three groups (2.2% vs. 4.7% vs. 4.3% vs. 13.2%, p < 0.001). The incidence of 
the secondary endpoint was similar among the four groups. Incorporation of high NLR and high DSBP 
into a model with conventional and meaningful clinical and procedural risk factors increased the  
C-statistics in predicting the primary endpoint (0.575 to 0.635, p = 0.002). 
Conclusions: The power to predict the primary endpoint after drug-eluting stent implantation at the 
5-year follow-up was improved by combining NLR and DSBP. (Cardiol J)
Key words: blood pressure difference, drug-eluting stent, neutrophil-to-lymphocyte  
ratio, outcomes, percutaneous coronary intervention
Introduction
The fundamental mechanism of coronary 
artery disease (CAD) is stenosis caused by inflam-
mation and atherosclerosis [1]. The earliest type of 
atherosclerotic lesion observed is a pure inflamma-
tory lesion composed mainly of monocyte-derived 
macrophages and T-lymphocytes [2]. Arbel et al. [3] 
demonstrated that a high neutrophil-to-lymphocyte 
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rates of 5-year mortality; therefore, the NLR could 
potentially be used to formulate prognosis in ad-
dition to conventional risk factors. Many other 
reports also emphasize the valuable role of NLR 
in CAD [4–6]. 
Another important causative factor of CAD 
is systolic arterial hypertension, which is associ-
ated with adverse cardiac events including such 
as death; as it is also associated with stress and 
other known psychosocial risk factors for CAD, it 
elevates the risk of cardiovascular sequelae [7, 8]. 
Coronary angiography (CAG) or percutaneous 
coronary intervention (PCI) may be accompanied 
by stress in healthy individuals. A meta-analysis 
suggested that greater responsiveness to acute 
mental stress has an adverse effect on future car-
diovascular risk status; for example, a composite 
of elevated blood pressure (BP), increased left 
ventricular mass, subclinical atherosclerosis, and 
clinical cardiac events [9]. It would be very informa-
tive if we could predict long-term prognosis of the 
patients who are going to have CAG or PCI before 
these operations begin. Her et al. [10] suggested 
that changes in peri-procedural BP may be signifi-
cantly associated with major adverse cardiac events 
and reported that a difference in the ward-to-cathe-
terization laboratory systolic BP (SBP) (DSBP) of 
> 20 mmHg was related to an increased rate of 
all-cause death and cardiac death (CD) after drug-
-eluting stent (DES) implantation. In actual clinical 
practice, minimally invasive or non-invasive, inex-
pensive diagnostic tools are preferred over invasive 
diagnostic tools in view of cost and patient safety 
[11]. In this regard, the NLR and DSBP are very 
useful non-invasive diagnostic tools for predicting 
adverse cardiac events. However, most previous 
studies [4–6, 10, 12] focused only on one of those 
two parameters. Moreover, data showing the com-
plementary actions and combined usefulness of 
NLR and DSBP in patients diagnosed with acute 
coronary syndrome (ACS) are limited. Therefore, 
we investigated the additional predictive power 
of the NLR and DSBP in comparison with that of 
conventional clinical and procedural risk factors 
in predicting 5-year major clinical outcomes after 
DES implantation.
Methods
Study design and population
This retrospective observational study en-
rolled 2023 consecutive eligible patients who un-
derwent PCI for ACS between September 2002 and 
August 2007 at the Cardiovascular Center of Ulsan 
University Hospital, Ulsan, South Korea. Data on 
cardiovascular risk factors and medical histories 
were self-reported by the patients. Patients were 
excluded if they had (1) stable angina (n = 171, 
8.5%); (2) any systemic diseases or treatment 
modality potentially affecting the white blood 
cells as shown in Figure 1 (n = 602, 29.8%); and 
(3) missing data or patients were lost to follow-up 
(n = 62, 3.1%). Finally, 1188 patients were included 
in the study (Fig. 1). The study protocol complied 
Exclusion
— Stable angina (n = 171)
— Hematologic disorders, malignancies, chemotherapy treatment,
     concomitant inammatory disease, acute infection, chronic
     inammantory conditions, history of corticosteroid therapy
     in the preceding 3 months, history of PCI or CVA, CABG, 
     secondary hypertension, heart failure, CKD, hepatic disease (n = 602)
— Missing data, or loss to follow-up (n = 62)
A total of 2023 consecutive eligible patients who underwent PCI from September 2002 and August 2007 
at the Cardiovascular Center of Ulsan University Hospital
Finally, 1188 patients were considered for inclusion
Group A Group B Group C Group D
Low NLR (£ 3.0),
Low DSBP (£ 25 mmHg),
n = 552
High DSBP (> 25 mmHg),
Low NLR (£ 3.0),
n = 383
High NLR (> 3.0),
Low DSBP (£ 25 mmHg),
n = 162
High DSBP (> 25 mmHg),
High NLR (> 3.0),
n = 91
Figure 1. Flow chart; CABG — coronary artery bypass grafting; CKD — chronic kidney disease; CVA — cardiovascular 
accidents; NLR — neutrophil-to-lymphocyte ratio; PCI — percutaneous coronary intervention; DSBP — differences in 
ward-to-catherization laboratory systolic blood pressure.
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with the ethical guidelines of the 1975 Declara-
tion of Helsinki and was approved by the Ulsan 
University Hospital Institutional Review Board. 
Written informed consent was obtained from all 
participants. The enrolled patients were required 
to visit the cardiology out-patient department at 
the end of the first month and every 3 to 6 months 
thereafter for 5 years for clinical follow-up data to 
be collected through face-to-face interviews, medi-
cal chart reviews, and telephone contact.
Study method and medical treatment
During admission, venous blood samples 
were taken to assess the following: (1) complete 
blood cell counts, which included total white 
blood cells, differential counts (neutrophils, lym-
phocytes, monocytes, eosinophils), red blood 
cell, and platelet counts; (2) cardiac enzymes 
(creatine kinase myocardial band [CK-MB] and 
cardiac troponin T); and (3) other blood chemistry 
parameters (high-sensitivity C-reactive protein, 
serum creatinine, estimated glomerular filtra-
tion rate [eGFR], and lipid profiles). NLR was 
defined as the ratio of the neutrophil count to the 
lymphocyte count. The method of BP measure-
ment has been described previously [10]. In brief, 
patients were measured with the  resting right 
arm BP in the supine position in a ward setting, 
before transfer to the catheterization laboratory, 
where it was measured again after the patients 
had laid down on the catheterization laboratory 
table prior to any arterial puncture or PCI (ward-
-to-catheterization laboratory BP difference). 
Differences were estimated in the systolic and 
diastolic BP and heart rate obtained in the ward 
and catheterization laboratory, with the measure-
ments taken by trained nurses using an ausculta-
tory sphygmomanometer. The BP and heart rate 
were measured twice for each location, with at 
least a 1-minute interval between recordings 
and the mean values were used in the analysis. 
The stents were deployed using standard PCI 
techniques [13]. A successful PCI was defined 
as an angiographic residual stenosis diameter of 
< 30% in the presence of thrombolysis in myocar-
dial infarction (TIMI) grade 3 flow. After DES im-
plantation, a minimum of 1 year of dual antiplatelet 
therapy was administered (100 mg acetylsalicylic 
acid daily and 75 mg clopidogrel daily). 
Study definitions and clinical endpoints
The primary endpoint was the composite of all-
cause death, CD, and non-fatal myocardial infarction 
(MI). The secondary endpoint was the composite of 
target lesion revascularization (TLR), target ves-
sel revascularization (TVR), and cerebrovascular 
accidents at 5-year follow-up. All-cause death was 
defined as either of CD or non-CD. Non-fatal MI 
was defined as the presence of clinical symptoms, 
electrocardiographic changes, or abnormal imag-
ing findings of MI, combined with an increase in 
the CK-MB fraction above the upper normal limits 
or an increase in troponin-T/troponin-I to greater 
than the 99th percentile of the upper normal limit 
after index PCI [14–16]. The definitions of TLR 
and TVR have been previously described [17]. The 
mean eGFR was calculated using the Modification 
of Diet in Renal Disease equation [18].
Statistical analysis
All statistical analyses were performed using 
SPSS v20 (IBM; Armonk, NY, USA). For continu-
ous variables, differences among the three groups 
were evaluated using the analysis of variance or 
the Jonckheere-Terpstra test, and post-hoc analy-
sis between the two groups was carried out using 
the Hochberg test or Dunnett-T3 test. Data are 
expressed as the means ± standard deviations. For 
discrete variables, the differences between two out 
of the three groups were analyzed using the c2 test 
or the Fisher exact test, as appropriate; data are 
expressed as counts and percentages [19]. In a mul-
tivariable Cox proportional hazard regression anal-
ysis, the baseline confounding covariates were se-
lected if they were significantly different (p < 0.001) 
among the four groups or between the two groups 
or had predictive values. The multivariable Cox 
proportional hazard regression analysis including 
baseline confounding factors, was used to compare 
the clinical endpoints among the four groups or 
between the two groups. Survival analysis among 
the four groups was performed using the Kaplan-
Meier method, and differences between the two 
groups were assessed using the log-rank test. 
Receiver operating characteristic (ROC) curves 
were used to differentiate the ability of the NLR 
and DSBP to predict primary endpoint (Fig. 2). 
After evaluating the relationship of the NLR and 
DSBP with the clinical outcomes using Cox pro-
portional hazard regression analysis, we compared 
the incremental value of combining a high NLR and 
a high DSBP into the context of conventional 
and meaningful clinical and procedural charac-
teristics for prediction of the primary endpoint. 
Estimates of the C-statistics for the Cox regres-
sion models were computed using the method of 
Pencina and D’Agostino [20]. Differences in the 
C-statistics (with 95% confidence interval [CI]) 
www.cardiologyjournal.org 3
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after the addition of the high NLR and high DSBP to 
a model with conventional and meaningful clinical 
and procedural risk factors were obtained using 
the bootstrap percentile method (200 replicates) 
[21]. The statistical significance level was set at 
a p-value of < 0.05 using a two-tailed test.
Results
Cutoff values for the NLR and DSBP
Analysis of the ROC curve was performed to 
detect the best NLR cutoff value that predicted 
the primary endpoint. This yielded a cutoff NLR 
of 3.0, with a sensitivity of 60.0%, a specificity 
of 47.2%, and an area under the ROC curve of 
0.605 (95% CI: 0.518–0.682) (Fig. 2). There-
fore, NLRs of > 3.0 (n = 253, 21.3%) and ≤ 3.0 
(n = 935, 78.7%) were considered to be high and 
low values, respectively. Thereafter, the subjects 
were sub-divided according to DSBP. In the same 
manner, an ROC curve analysis was used to de-
tect the best cutoff value of DSBP for predicting 
the primary endpoint. This yielded a cutoff DSBP 
of 25 mmHg, with a sensitivity of 63.0%, a speci-
ficity of 52.0%, and an area under the ROC curve 
of 0.612 (95% CI: 0.528–0.691; Fig. 2). DSBP 
> 25 mmHg (n = 474, 39.9%) and ≤ 25 mmHg 
(n = 714, 60.1%) were considered to be high and 
low values, respectively. The patients were clas-
sified into four groups according to the NLR and 
DSBP (high vs. low) using the cutoffs derived 
from the analysis of the ROC curves: group A (low 
NLR [≤ 3.0] and low DSBP [≤ 25 mmHg], n = 552, 
46.5%), group B (high DSBP [> 25 mmHg] and 
low NLR [≤ 3.0], n = 383, 32.2%), group C (high 
NLR [> 3.0] and low DSBP [≤ 25 mmHg], n = 162, 
13.6%), and group D (high DSBP [> 25 mmHg] and 
high NLR [> 3.0], n = 91, 7.7%). 
Baseline clinical and angiographic  
characteristics
The baseline laboratory and angiographic 
characteristics according to the NLR and DSBP 
are summarized in Table 1. The mean age of the 
total study population was 60.5 ± 10.3 years, and 
the oldest patient was included in group D. The 
mean left ventricular ejection fraction (LVEF) of 
the total study population was 61.6 ± 10.3%. The 
number of patients with hypertension and unsta-
ble angina was the highest in group B. The number 
of acute MI was the highest in group C. The mean 
serum creatinine level was the highest in group D. 
However, the number of patients with a his-
tory of diabetes mellitus, dyslipidemia, and MI; 
number with left anterior descending artery, left 
circumflex artery, and right coronary artery as the 
treated vessels; American College of Cardiology/ 
/American Heart Association lesion type; extent 
of CAD; number of deployed stents; mean di-
ameter of deployed stents; and mean length of 
deployed stents were not significantly different 
among the four groups.
Figure 2. Receiver operating characteristic curve of neutrophil-to-lymphocyte ratio (NLR) and difference in the ward-
-to-catheterization laboratory systolic blood pressure (DSBP) for primary endpoints.
4 www.cardiologyjournal.org
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Clinical outcomes
The cumulative incidence of the primary 
endpoint, all-cause death, CD, and secondary 
endpoint are summarized in Table 2, Figure 3, 
and Supplemental Online Material 1. After 
adjustment, the cumulative incidence of the pri-
mary endpoint in group D was significantly higher 
than that in group A (adjusted hazard ratio [aHR]: 
1.920; 95% CI: 1.462–2.522; p < 0.001), group B 
(aHR: 1.751; 95% CI: 1.186–2.584; p = 0.005), 
and group C (aHR: 3.514; 95% CI: 1.481–9.640; 
p = 0.015) (Table 2, Fig. 3A). Similarly, the cumula-
tive incidence of all-cause death was significantly 
higher in group D than in group A (aHR: 2.466; 95% 
CI: 1.721–3.532; p < 0.001), group B (aHR: 1.767; 
95% CI: 1.168–2.603; p = 0.007), and group C (aHR: 
3.191; 95% CI: 1.065–9.557; p = 0.038) (Table 2, Fig. 
3B). The cumulative incidence of CD in group D was 
significantly higher than that in group A (aHR: 3.394; 
95% CI: 1.627–7.079; p = 0.001) and group B (aHR: 
3.185; 95% CI: 1.228–7.014; p = 0.017) (Table 2, 
Fig. 3C). The cumulative incidence of secondary 
endpoint was not significantly different among the 
four groups (Suppl. Online Material 1, Fig. 3D). 
Table 3 summarizes improvements in C-statistics 
in predicting the primary endpoint when high NLR 
and high DSBP were added into the model with con-
ventional and meaningful clinical and procedural risk 
factors. The addition of high NLR and high DSBP 
led to significant improvements in C-statistics from 
0.575 to 0.602 (p = 0.017) and 0.622 (p = 0.004), 
respectively. However, the greatest improvement 
in C-statistics was seen when both high NLR 
and high DSBP were combined into the model, 
with C-statistics increasing significantly to 0.635 
(p = 0.002). Table 4 shows independent predictors 
of the primary and secondary endpoints at 5 years. 
Low LVEF (< 50%), hypertension, lymphocyte 
count, and catheterization laboratory SBP were 
found to be meaningful independent predictors of 
the primary endpoint. Additionally, diabetes mellitus 
was found to be a meaningful independent predictor 
of the secondary endpoint.
Discussion
The main findings of this study are the fol-
lows. The cumulative incidence of the primary 
endpoint in group D was significantly higher than 
that in the other three groups and the incorporation 
of high NLR and high DSBP into the model with 
conventional and meaningful clinical and procedural 
risk factors synergistically increased the ability to 
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Table 3. C-statistics for Cox regression models for prediction of primary endpoint.
Meaningful risk factors, NLR and DSBP C-statistics Estimated difference  
(95% CI)
P value
Meaningful clinical and procedural risk factors* 0.575 Reference Reference
Meaningful clinical and procedural risk factors  
plus high NLR
0.602 0.055 (–0.107 to 0.108) 0.017
Meaningful clinical and procedural risk factors  
plus high DSBP
0.622 0.050 (–0.099 to 0.099) 0.004
Meaningful clinical and procedural risk factors  
plus high NLR and high DSBP
0.635 0.048 (–0.093 to 0.094) 0.002
*Meaningful clinical and procedural risk factors composed of men, age, hypertension, unstable angina, non-STEMI, STEMI, left ventricular 
ejection fraction, white blood cell, neutrophil, lymphocyte, monocyte, eosinophil, hemoglobin, NLR, ward SBP, catheterization laboratory SBP, 
DSBP, hs-CRP, serum creatinine, peak CK-MB, peak troponin-T; NLR — neutrophil-to-lymphocyte ratio; SBP — systolic blood pressure; DSBP 
— difference in ward-to-catheterization laboratory SBP; STEMI — ST-segment elevation myocardial infarction; hs-CRP — high sensitivity-C-
-reactive protein; CK-MB — creatine kinase myocardial band; CI — confidence interval
Figure 3. Kaplan-Meier analysis for primary outcome (A), all-cause death (B), cardiac death (C), and secondary end-
-point (D).
10 www.cardiologyjournal.org
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Because previous work has highlighted the 
importance of the NLR and DSBP in predicting 
long-term major clinical outcomes in patients 
with ACS who underwent PCI, we investigated 
combined usefulness of these two non-invasive, 
inexpensive, relatively simple, not to mention the 
little time required employing the diagnostic tools 
in this study. The present study showed the addi-
tive value and combined usefulness of the NLR 
and DSBP in predicting the primary endpoint in 
patients with ACS after DES implantation. Accord-
ing to available research, this study is the first to 
report the additive benefit of the NLR and DSBP 
in predicting the 5-year follow-up of clinical out-
comes in patients with ACS undergoing PCI with 
DES implantation.
Vascular inflammation plays a critical role in 
the initiation, evolution, and rupture of athero-
sclerotic plaques [22]. The circulating biomarkers 
of this process predict morbidity and mortality in 
patients with established CAD [23, 24]. To date, 
there has been diverse evidence regarding the role 
of the NLR, which suggests that it has an associa-
tion with CAD [25, 26] and that it could predict 
adverse in-hospital mortality and long-term mortal-
ity up to 3 years [26]. In this study, the NLR had 
an additional good prognostic value for predicting 
the primary endpoint during the 5-year follow-up 
(increase in C-statistics from 0.575 to 0.602; p = 
0.017). In addition, the cumulative incidence of the 
primary endpoint was higher in the high NLR group 
than in the low NLR group (aHR: 2.499; 95% CI: 
1.285–4.857; p = 0.007; Table 2). These results 
are compatible with those of previous reports [3, 5, 
25]. In patients with ACS, a low lymphocyte count 
is common and can be explained by the elevated 
cortisol level, which induces apoptosis [27]. This 
low lymphocyte count (i.e., high NLR) is associ-
ated with adverse clinical outcomes [6]. In this 
study, the frequency of the primary endpoint was 
significantly higher in the high DSBP group than in 
the low DSBP group at 5 years (aHR: 2.379; 95% 
CI: 1.262–4.218; p = 0.007; Table 2). It is well 
known that target organ damage in patients with 
hypertension and cardiovascular complications is 
related to elevated BP, which is determined from 
the average of multiple BP readings (mean BP) 
[28]. DSBP may not be a good substitute of 24-hour 
ambulatory BP monitoring (ABPM). However, 
ABPM is an additional diagnostic test with inherent 
costs and takes more time to get results compared 
to DSBP. Therefore, we thought that DSBP may 
be the preferred technique for the patients with 
ACS. Moreover, BP measurement in the ward and 
before catheterization is already done in routine 
clinical practice. 
Although the NLR and DSBP have a different 
pathophysiological mechanism, they both lead to 
accelerated atherosclerosis. In patients with ACS, 
an increased total leukocyte count predicts mor-
tality and recurrence of MI [29, 30]. ACS is most 
commonly caused by disruption of atherosclerotic 
plaques with superimposed thrombus formation; 
thus, inflammation plays a crucial role in the 
pathogenesis of acute coronary events [31]. To 
date, the precise mechanism of acute transient BP 
elevation is less well known. Under stressful situ-
ations (e.g., CAG or PCI), increased activity of the 
hypothalamic-pituitary-adrenal axis culminating in 
release of with catecholamine play a vital role in 
initiating acute deviations from normal physiol-
ogy such as hypertension. Through changes in 
the circulating catecholamine levels, emotional or 
psychosocial stress evokes negative effects on au-
tonomic and hormonal homeostasis, which can lead 
to inflammation, metabolic abnormalities, endothe-
lial dysfunction, hypertension, and insulin resist-
ance [32]. From a different perspective, increased 
cardiac output and arterial stiffness under stressful 
circumstances are related to acute BP responses; 
the latter are associated with atherosclerosis [33, 
34]. Her et al. [10] proposed that an acute eleva-
tion of BP under stress might contribute to an 
increased risk of adverse clinical outcomes, with 
this BP elevation representing significant arterial 
atherosclerosis and increased arterial stiffness. 
Another possible interaction between BP and NLR 
is that an elevated BP increases the formation of 
hydrogen peroxide and free radicals in the plasma 
[35], and these substrates cause decreased pro-
duction of nitric oxide from the endothelium [36] 
and increased leukocyte adhesion [37]. Therefore, 
these two parameters are associated with each 
other. Because atherosclerosis is an inflamma-
tory disease and an important causative factor of 
BP variations, early detection and modification of 
these reversible factors may reduce the frequency 
and severity of adverse cardiac events during long-
term follow-up after implantation of DESs. In this 
regard, the combined use of the NLR and DSBP 
as a predictive tool for adverse cardiac events is 
a rational approach, especially in patients under-
going PCI. Finally, although in this study shows 
the additional combined usefulness of the NLR 
and DSBP in predicting long-term outcomes after 
implantation of DESs, other laboratory (e.g., GFR, 
hemoglobin), clinical features, or well-established 
risk assessment tools (e.g., Global Registries of 
12 www.cardiologyjournal.org
Cardiology Journal 20XX, Vol. XX, No. X
Acute Coronary Events [GRACE] or TIMI risk 
scores) could also be used as alternatives for these 
two parameters in further studies.
Limitations of the study
This study has some limitations. First, the 
NLR was checked only once; thus, it was not known 
whether there was any change in its value. Sec-
ond, even though there was an attempt to perform 
a multivariable Cox proportional hazard regression 
analysis including baseline confounding factors, 
as this study was a non-randomized retrospective 
single-center study with several exclusion crite-
ria, selection bias cannot be excluded. Third, the 
sample size may not be sufficiently large enough to 
accurately estimate the study results. Larger rand-
omized prospective studies are required to confirm 
these results. Fourth, group D was composed of 
a stringently selected population. Therefore, this 
may have led to selection bias. Fifth, because 
24-hour ABPM was not performed in this study, 
assessment of any BP variability was not possible. 
Finally, the patients in this study were enrolled 
between September 2002 and August 2007; this 
limited study period can be considered to be the 
main limitation.
Conclusions
In conclusion, in this retrospective observa-
tional study of the patients with ACS, the incor-
poration of both high NLR and high DSBP into the 
model with conventional and meaningful clinical 
and procedural risk factors increased the ability 
to predict the primary endpoint during the 5-year 
follow-up period.
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